Attention biotech/pharma researchers: sign up for Endpoints News!
Thursday, September 21, 2017 - 15:00
Endpoints News is an independent news organization, reporting and analyzing the top global biotech and pharmaceutical R&D news of the day.
We produce original editorial on a daily basis on business deals, buyouts and corporate reorganizations to FDA actions and the latest clinical data on some of the world’s most closely watched drugs. A must-read in the biotech community only months after our June 2016 launch, Endpoints News also caters to a growing audience of investors interested in the latest news on the business of drug development.
Our license license grants every Tulane affiliate access ot the Early Edition and Feature Edition emails, along with reprint rights of Endpoints News content, VIP email support, and more.
Simply sign up for the basic/free account here using your Tulane email address and the system will automatically recognize the domain (@tulane.edu).
For more information about the Tulane Office of Research Business Development, visit engage.tulane.edu.